GW gets $5 million high on Novartis deal for Sativex
11 April 2011
Sukaina Virji
Please Login to read the full article.
11 April 2011
Sukaina Virji
sukaina.virji@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- GW Pharmaceuticals to let Almirall sell cannabis-derived drug in Mexico
- Sigma-Tau acquires additional rights to angioedema product from Dyax
- Pfizer, Biocon abort alliance as business differences outweigh [bio]similarities
- BMS and Sanofi mentioned in $1bn deal speculation over Biocon's oral insulin
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
